CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX), a specialty pharmaceutical company, is focused on the development, licensing and commercialization of pharmaceutical products through the leveraging of their validated drug delivery technology. The company has U.S. and international patents as well as other proprietary rights to technologies that encourage the absorption of drugs. For further information, visit the Company’s web site at www.cpexpharm.com.
- 17 years ago
QualityStocks
CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Launches 12-Month AI-Driven Marketing Campaign With AGORACOM
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced a 12-month online marketing campaign with…
-
QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Strengthens Balance Sheet with Full Conversion of $13.3 Million Notes
Datavault AI (NASDAQ: DVLT), a pioneer in AI-driven data monetization, announced the full conversion of…
-
Nightfood Holdings Inc. (NGTF) Offering a Portfolio of AI-Powered Robots Designed to Streamline Operations and Enhance Efficiency
Nightfood Holdings has a lineup of AI-powered robots to streamline operations across industries, weaving technology…